176 results
Page 5 of 9
8-K
EX-99.1
6rphmr32lwc
4 Nov 19
Karyopharm Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
7:07am
8-K
EX-99.1
88wty9g r3o00q4fhft
6 Aug 19
Results of Operations and Financial Condition
7:13am
424B5
7jg8478796t3vj
10 May 19
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
qdn02xba 2q0xs06cl2
9 May 19
Results of Operations and Financial Condition
7:10am
PRE 14A
aispjqbxkbmyokm69ty
2 Apr 19
Preliminary proxy
4:29pm
POS AM
z57tfh
28 Feb 19
Prospectus update (post-effective amendment)
4:54pm
POSASR
qf8vb v6xy5
28 Feb 19
Automatic shelf registration (post-effective amendment)
4:17pm
8-K
EX-10.2
ktuli 2i73yrcp1ax0
25 Feb 19
Departure of Directors or Certain Officers
5:01pm
8-K
m57uiw3q 56eaiwpzo
25 Feb 19
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
srqdixq7s6brp4
18 Jan 19
Departure of Directors or Certain Officers
4:06pm
8-K
EX-99.1
gudetftmeh0h2k
8 Nov 18
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
7:08am
8-K
EX-4.1
syir4mmutnxq ln
16 Oct 18
Entry into a Material Definitive Agreement
4:18pm
424B5
dsh3gmpmnz5m 709dab
17 Aug 18
Prospectus supplement for primary offering
4:05pm
8-K
EX-10.1
89mseq4q 73k
17 Aug 18
Entry into a Material Definitive Agreement
4:01pm